Position in GILD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$117,456,023
-$161,331,780 QoQ
Shares Held
929,682
-53.5% QoQ
Ownership
0.075%
of shares outstanding
% of Portfolio
0.36%
of 13F equity value
Holder Rank
#131
of 2,266 holders
Holding Since
Mar 2020
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LORD, ABBETT & CO. LLC holds $1,248,570,920 across 7 Drug Manufacturers - General names. GILD ranks #4 (9.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
427,913 | $513,251,732 | |
| 2 | JNJ |
Johnson & Johnson
|
1,477,212 | $375,167,531 | |
| 3 | NVS |
Novartis AG
|
1,002,335 | $157,085,941 | |
| 4 | GILD |
Gilead Sciences, Inc.
This page
|
929,682 | $117,456,023 | |
| 5 | ABBV |
AbbVie Inc.
|
180,108 | $45,322,377 | |
| 6 | BIIB |
Biogen Inc.
|
130,184 | $28,127,555 | |
| 7 | AZN |
Astrazeneca PLC
|
64,127 | $12,159,761 |
All Filings in GILD
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $117,456,023 | 929,682 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $278,787,803 | 2,000,343 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $148,417,453 | 1,209,202 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $133,607,814 | 1,203,674 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $124,527,520 | 1,123,185 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $167,108,792 | 1,491,377 | Shares | Sole | 2025-05-13 | |
| 2023-03-31 | $433,103 | 5,220 | Shares | Sole | 2024-10-07 | |
| 2022-12-31 | $447,278 | 5,210 | Shares | Sole | 2024-10-07 | |
| 2022-09-30 | $1,785,925 | 28,950 | Shares | Sole | 2022-11-14 | |
| 2020-03-31 | $36,362,516 | 486,390 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||